Vigil Neuro
Julia Keefe currently serves as Associate Director at Vigil Neuroscience, a position held since March 2023. Previous experience includes Associate Director roles at Tango Therapeutics and Acceleron Pharma, where responsibilities included managing corporate communications, overseeing website redesign, and partnering with various teams for strategic initiatives. At Acceleron Pharma, Julia played a key role in investor and media communications around milestone announcements, including FDA approval processes. Earlier professional experiences include HR Specialist and Recruiting Coordinator positions at Agios Pharmaceuticals and KNF&T Staffing Resources, respectively. Julia holds a Bachelor's Degree in History from Boston College.
This person is not in any teams
Vigil Neuro
Vigil Neuroscience is the world’s first microglia-focused therapeutics company. Their purpose is clear: to treat rare and common neurodegenerative diseases by restoring the vigilance of the microglia, the sentinel cells of the brain’s immune system. They are utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and their families.